Literature DB >> 9447959

The CD38-cyclic ADP-ribose signalling system in insulin secretion: molecular basis and clinical implications.

H Okamoto1, S Takasawa, K Nata.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 9447959     DOI： 10.1007/s001250050854

Source DB:  PubMed          Journal:  Diabetologia        ISSN： 0012-186X            Impact factor:   10.122


× No keyword cloud information.
  12 in total

1.  Anti-CD38 autoimmunity in patients with chronic autoimmune thyroiditis or Graves' disease.

Authors:  A Antonelli; P Fallahi; C Nesti; C Pupilli; P Marchetti; S Takasawa; H Okamoto; E Ferrannini
Journal:  Clin Exp Immunol       Date:  2001-12       Impact factor: 4.330

2.  The enzymatic activities of CD38 enhance CLL growth and trafficking: implications for therapeutic targeting.

Authors:  T Vaisitti; V Audrito; S Serra; R Buonincontri; G Sociali; E Mannino; A Pagnani; A Zucchetto; E Tissino; C Vitale; M Coscia; C Usai; C Pepper; V Gattei; S Bruzzone; S Deaglio
Journal:  Leukemia       Date:  2014-07-03       Impact factor: 11.528

3.  The CD38-cyclic ADP-ribose signaling system in insulin secretion.

Authors:  H Okamoto
Journal:  Mol Cell Biochem       Date:  1999-03       Impact factor: 3.396

Review 4.  CD38 and airway hyper-responsiveness: studies on human airway smooth muscle cells and mouse models.

Authors:  Alonso G P Guedes; Deepak A Deshpande; Mythili Dileepan; Timothy F Walseth; Reynold A Panettieri; Subbaya Subramanian; Mathur S Kannan
Journal:  Can J Physiol Pharmacol       Date:  2014-12-09       Impact factor: 2.273

Review 5.  CD38 in the pathogenesis of allergic airway disease: Potential therapeutic targets.

Authors:  Deepak A Deshpande; Alonso G P Guedes; Frances E Lund; Subbaya Subramanian; Timothy F Walseth; Mathur S Kannan
Journal:  Pharmacol Ther       Date:  2016-12-07       Impact factor: 12.310

Review 6.  Harnessing NAD+ Metabolism as Therapy for Cardiometabolic Diseases.

Authors:  Akash Chakraborty; Keaton E Minor; Hina Lateef Nizami; Ying Ann Chiao; Chi Fung Lee
Journal:  Curr Heart Fail Rep       Date:  2022-05-13

Review 7.  Anti-CD38 autoantibodies in type? diabetes.

Authors:  Roberto Mallone; Paolo Cavallo Perin
Journal:  Diabetes Metab Res Rev       Date:  2006 Jul-Aug       Impact factor: 4.876

8.  cAMP-dependent mobilization of intracellular Ca2+ stores by activation of ryanodine receptors in pancreatic beta-cells. A Ca2+ signaling system stimulated by the insulinotropic hormone glucagon-like peptide-1-(7-37).

Authors:  G G Holz; C A Leech; R S Heller; M Castonguay; J F Habener
Journal:  J Biol Chem       Date:  1999-05-14       Impact factor: 5.157

9.  Autoantibodies against CD38 (ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase) that impair glucose-induced insulin secretion in noninsulin- dependent diabetes patients.

Authors:  F Ikehata; J Satoh; K Nata; A Tohgo; T Nakazawa; I Kato; S Kobayashi; T Akiyama; S Takasawa; T Toyota; H Okamoto
Journal:  J Clin Invest       Date:  1998-07-15       Impact factor: 14.808

10.  Decreased ADP-ribosyl cyclase activity in peripheral blood mononuclear cells from diabetic patients with nephropathy.

Authors:  Michio Ohtsuji; Kunimasa Yagi; Miyuki Shintaku-Kubota; Yukiko Kojima-Koba; Naoko Ito; Masako Sugihara; Naoto Yamaaki; Daisuke Chujo; Atsushi Nohara; Yoshiyu Takeda; Junji Kobayashi; Masakazu Yamagishi; Haruhiro Higashida
Journal:  Exp Diabetes Res       Date:  2009-03-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.